Photo of Angela Lamarca from X
Jul 4, 2024, 12:15
Angela Lamarca: We MUST validate innovate biomarkers in clinical trials
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:
“Last session of the day on Precision Medicine in European Network for the Study of Cholangiocarcinoma (ENS-CCA), Precision-BTC-Network joint meeting in Krakow.
- surgical candidates
- neoadjuvant
- chemoresistance?
- markers for IO
- new markers- circRNAs
We MUST validate innovate biomarkers in clinical trials.”
Source: Angela Lamarca/X
Angela Lamarca
biomarkers
cancer
Chemoresistance
cholangiocarcinoma
circRNAs
clinical trials
ENS-CCA
European Network for the Study of Cholangiocarcinoma
HPB Oncologist
immunotherapy
Jimenez Diaz Foundation
neoadjuvant therapy
NET Oncologist
OncoDaily
Oncology
Precision Medicine
Precision-BTC-Network